A bill to provide for the issuance of an Alzheimer's Disease Research Semipostal Stamp.

Directs the United States Postal Service (USPS) to issue and sell an Alzheimer's Disease Research Semipostal Stamp.

Requires proceeds from the sale of the stamp to be transferred to the National Institutes of Health.

Requires the stamp to be made available to the public for six years.

[Congressional Bills 113th Congress]
[From the U.S. Government Publishing Office]
[S. 1091 Introduced in Senate (IS)]

113th CONGRESS
  1st Session
                                S. 1091

    To provide for the issuance of an Alzheimer's Disease Research 
                           Semipostal Stamp.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                              June 4, 2013

 Ms. Mikulski introduced the following bill; which was read twice and 
referred to the Committee on Homeland Security and Governmental Affairs

_______________________________________________________________________

                                 A BILL


 
    To provide for the issuance of an Alzheimer's Disease Research 
                           Semipostal Stamp.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. ALZHEIMER'S DISEASE RESEARCH SEMIPOSTAL STAMP.

    (a) In General.--In order to afford a convenient way for members of 
the public to contribute to funding for medical research relating to 
Alzheimer's disease, the United States Postal Service shall issue a 
semipostal stamp (referred to in this Act as the ``Alzheimer's Disease 
Research Semipostal Stamp'') in accordance with the provisions of this 
section.
    (b) Terms and Conditions.--
            (1) In general.--The issuance and sale of the Alzheimer's 
        Disease Research Semipostal Stamp shall be governed by the 
        provisions of section 416 of title 39, United States Code, and 
        regulations issued under such section, subject to the 
        requirements of this subsection.
            (2) Duration.--The Alzheimer's Disease Research Semipostal 
        Stamp shall be made available to the public for a period of 6 
        years, beginning no later than 12 months after the date of the 
        enactment of this Act.
            (3) Disposition of proceeds.--All amounts becoming 
        available from the sale of the Alzheimer's Disease Research 
        Semipostal Stamp (as determined under section 416(d) of such 
        title 39) shall be transferred to the National Institutes of 
        Health, for the purpose described in subsection (a), through 
        payments which shall be made at least twice a year.
    (c) Definition.--For purposes of this Act, the term ``semipostal 
stamp'' refers to a stamp described in section 416(a)(1) of title 39, 
United States Code.
                                 <all>